Individuals over 50, you likely need supplemental B12
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
This advanced protocol is not for beginners and requires careful monitoring and medical supervision
The dosing rhythm is set by your prescribing provider based on the indication, your individual factors, and tolerability, not by a fixed universal schedule
"Expanded Recycling Site Upsets an Ossining Neighborhood"